Skip to content

Hear patients and sites before the protocol locks.

Patient experience and protocol feedback, site and investigator engagement - the input that de-risks recruitment and retention, gathered in a structured, moderated room.

Book a demoSame platform, same guarantee. Only the scenario changes.
The problem

The feedback trials never quite get

  • Protocol burden is discovered in recruitment shortfalls and dropouts - after design decisions have locked.
  • Site and investigator insight arrives ad hoc, through monitors and emails, unattributed and easy to discount.
  • Patients who’ve lived the trial experience are the hardest to convene and the easiest to under-hear.
How Rumi runs it

One platform. This scenario.

  1. Patient-experience panels

    Patients and advocates respond to protocol and experience questions from home, at their own pace, in plain language.

  2. Site & investigator rooms

    Structured feedback from sites on feasibility, burden and design - captured, attributed and organised.

  3. Decision-ready input

    Feedback lands as an organised record the study team can weigh before decisions lock - not anecdotes after.

Why Rumi wins here

Recruitment & retention de-risked

Burden and design issues surface before they become enrolment shortfalls.

Every site, every patient panellist

The participation guarantee brings the full panel’s view - not the two sites that always answer.

A record trials can rely on

Attributed, auditable feedback - input the study team can cite in design decisions.

Scope, honestly

Rumi supports feedback and engagement use around trials - patient experience, protocol design input, site and investigator engagement. It is not offered as a validated GxP system (21 CFR Part 11 / ICH-GCP electronic-records use); trial-adjacent engagements are scoped to non-GxP feedback use cases, and we’ll tell you plainly where that line sits for your program.

In production with global pharma
AstraZenecaBayerPharmingAmgenNovartisRecordati Rare DiseasesSobiMenarini
The guarantee travels

100% participation is as binding here as on an advisory board.

Same monitoring, same moderator tools, same written terms: a defined panel, a defined bar for participation, and a remedy if we miss.

Clinical trials - patient & site feedback: your questions

How can Rumi be used in clinical trials?

For structured feedback and engagement around the trial: patient-experience and protocol-design input, site feasibility feedback and investigator engagement - run as moderated asynchronous panels with an attributed, organised record. Engagements are scoped to non-GxP feedback use cases.

Is Rumi a validated GxP system?

No - Rumi is not offered as a validated system for GxP electronic records (21 CFR Part 11 / ICH-GCP). Trial-adjacent work is deliberately scoped to feedback and engagement use cases, and we are explicit about where that boundary sits for each program.

See every voice heard, in full, on your own use case.

Book a demo
Thirty minutes with Steve Royle, founder, on your use case.